Status:
COMPLETED
The Effect of Methods Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Fever
Heart Rate
Eligibility:
All Genders
Up to 24 years
Phase:
NA
Brief Summary
Fever, one of the most common clinical journeys of childhood, makes up a fraction of emergency room admissions. About us-30. High fever, which is one of the first schools in infancy and childhood, can...
Eligibility Criteria
Inclusion
- Applying to the pediatric emergency department with a complaint of high fever (38ºC).
- Being prescribed an antipyretic (paracetamol) by a physician.
- Those whose parents are literate and agree to participate in the study.
- Patients with triage color classification Yellow and Green.
- Children between 0-24 months will be included in the study.
Exclusion
- Having used antipyretics in the last 6 hours.
- Being prescribed an antipyretic other than paracetamol by the physician.
- Having trouble in sucking-swallowing coordination.
- Children with chronic disease and neuromotor developmental delay.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05366049
Start Date
November 1 2020
End Date
August 30 2022
Last Update
December 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Unisversity- Cerrahpasa
Istanbul, Fatih, Turkey (Türkiye), 34320